Schicht, M.; Sisignano, M.; Farger, J.; Wedel, S.; Phunchago, N.; Perumal, N.; Manicam, C.; Scholich, K.; Geisslinger, G.; Paulsen, F.;
et al. Ocular Surface Changes Differ Significantly Between Oxaliplatin- and Diabetes-Induced Polyneuropathy. Int. J. Mol. Sci. 2025, 26, 1884.
https://doi.org/10.3390/ijms26051884
AMA Style
Schicht M, Sisignano M, Farger J, Wedel S, Phunchago N, Perumal N, Manicam C, Scholich K, Geisslinger G, Paulsen F,
et al. Ocular Surface Changes Differ Significantly Between Oxaliplatin- and Diabetes-Induced Polyneuropathy. International Journal of Molecular Sciences. 2025; 26(5):1884.
https://doi.org/10.3390/ijms26051884
Chicago/Turabian Style
Schicht, Martin, Marco Sisignano, Jessica Farger, Saskia Wedel, Nichapa Phunchago, Natarajan Perumal, Caroline Manicam, Klaus Scholich, Gerd Geisslinger, Friedrich Paulsen,
and et al. 2025. "Ocular Surface Changes Differ Significantly Between Oxaliplatin- and Diabetes-Induced Polyneuropathy" International Journal of Molecular Sciences 26, no. 5: 1884.
https://doi.org/10.3390/ijms26051884
APA Style
Schicht, M., Sisignano, M., Farger, J., Wedel, S., Phunchago, N., Perumal, N., Manicam, C., Scholich, K., Geisslinger, G., Paulsen, F., & Lütjen-Drecoll, E.
(2025). Ocular Surface Changes Differ Significantly Between Oxaliplatin- and Diabetes-Induced Polyneuropathy. International Journal of Molecular Sciences, 26(5), 1884.
https://doi.org/10.3390/ijms26051884
